Tat (HIV) (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tat (HIV)" in Japanese language version.

refsWebsite

Global rank Japanese rank

37nih.gov

4^th place

24^th place

22doi.org

2^nd place

6^th place

4harvard.edu

18^th place

107^th place

1zenodo.org

621^st place

4,635^th place

doi.org

“The ins and outs of HIV-1 Tat.”. Traffic 13 (3): 355–63. (2012). doi:10.1111/j.1600-0854.2011.01286.x. PMID 21951552.
“Positive transcription elongation factor B phosphorylates hSPT5 and RNA polymerase II carboxyl-terminal domain independently of cyclin-dependent kinase-activating kinase”. J. Biol. Chem. 276 (15): 12317–23. (April 2001). doi:10.1074/jbc.M010908200. PMID 11145967.
“Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1”. Proc. Natl. Acad. Sci. U.S.A. 97 (21): 11466–71. (October 2000). Bibcode: 2000PNAS...9711466X. doi:10.1073/pnas.97.21.11466. PMC 17223. PMID 11027346.
“The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis”. J. Biol. Chem. 279 (46): 48197–204. (November 2004). doi:10.1074/jbc.M406195200. PMID 15331610.
“The biochemistry of AIDS”. Annu. Rev. Biochem. 60: 577–630. (1991). doi:10.1146/annurev.bi.60.070191.003045. PMID 1883204.
“NMR structure of a biologically active peptide containing the RNA-binding domain of human immunodeficiency virus type 1 Tat”. Proc. Natl. Acad. Sci. U.S.A. 91 (17): 8248–52. (August 1994). Bibcode: 1994PNAS...91.8248M. doi:10.1073/pnas.91.17.8248. PMC 44583. PMID 8058789.
“A bimolecular mechanism of HIV-1 Tat protein interaction with RNA polymerase II transcription elongation complexes”. J. Mol. Biol. 320 (5): 925–42. (July 2002). doi:10.1016/S0022-2836(02)00556-9. PMID 12126615.
“Trans-activation by HIV-1 Tat via a heterologous RNA binding protein”. Cell 62 (4): 769–76. (August 1990). doi:10.1016/0092-8674(90)90121-T. PMID 2117500.
“Crystal structure of HIV-1 Tat complexed with human P-TEFb”. Nature 465 (7299): 747–51. (June 2010). Bibcode: 2010Natur.465..747T. doi:10.1038/nature09131. PMC 2885016. PMID 20535204.
“Direct interaction of human TFIID with the HIV-1 transactivator Tat”. Nature 367 (6460): 295–9. (January 1994). Bibcode: 1994Natur.367..295K. doi:10.1038/367295a0. PMID 8121496.
“Protein transduction: unrestricted delivery into all cells?”. Trends Cell Biol. 10 (7): 290–5. (July 2000). doi:10.1016/S0962-8924(00)01771-2. PMID 10856932.
“Delivery of bioactive molecules into the cell: the Trojan horse approach”. Molecular and Cellular Neuroscience 27 (2): 85–131. (October 2004). doi:10.1016/j.mcn.2004.03.005. PMID 15485768. https://zenodo.org/record/890801.
“Cellular uptake of the tat protein from human immunodeficiency virus”. Cell 55 (6): 1189–93. (December 1988). doi:10.1016/0092-8674(88)90263-2. PMID 2849510.
“Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein”. Cell 55 (6): 1179–88. (December 1988). doi:10.1016/0092-8674(88)90262-0. PMID 2849509.
MacKay, J. Andrew; Szoka, Jr., Francis C. (2003). “HIV TAT Protein Transduction Domain Mediated Cell Binding and Intracellular Delivery of Nanoparticles”. Journal of Dispersion Science and Technology 24 (3): 465–473. doi:10.1081/dis-120021802. PMC 2929673. PMID 20808712.
Silhol, Michelle; Tyagi, Mudit; Giacca, Mauro; Lebleu, Bernard; Vivès, Eric (2002). “Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat”. European Journal of Biochemistry 269 (2): 494–501. doi:10.1046/j.0014-2956.2001.02671.x. PMID 11856307.
Eguchi, Akiko; Akuta, Teruo; Okuyama, Hajime et al. (2001). “Protein Transduction Domain of HIV-1 Tat Protein Promotes Efficient Delivery of DNA into Mammalian Cells”. Journal of Biological Chemistry 276 (28): 26204–26210. doi:10.1074/jbc.M010625200. PMID 11346640.
“Structural and functional characterization of human immunodeficiency virus Tat protein”. Journal of Virology 63 (1): 1–8. (January 1989). doi:10.1128/JVI.63.1.1-8.1989. PMC 247650. PMID 2535718.
“Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein”. Journal of Virology 63 (3): 1181–7. (March 1989). doi:10.1128/JVI.63.3.1181-1187.1989. PMC 247813. PMID 2536828.
“Recruitment of phosphatidylinositol 3-kinase to CD28 inhibits HIV transcription by a Tat-dependent mechanism”. J. Immunol. 169 (1): 254–60. (July 2002). doi:10.4049/jimmunol.169.1.254. PMID 12077252.
“4-Phenylcoumarins as HIV transcription inhibitors”. Bioorg. Med. Chem. Lett. 15 (20): 4447–50. (October 2005). doi:10.1016/j.bmcl.2005.07.041. PMID 16137881.
“Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial”. Retrovirology 13: 21. (April 2016). doi:10.1186/s12977-016-0251-3. PMC 4818470. PMID 27036656.

harvard.edu

ui.adsabs.harvard.edu

“Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1”. Proc. Natl. Acad. Sci. U.S.A. 97 (21): 11466–71. (October 2000). Bibcode: 2000PNAS...9711466X. doi:10.1073/pnas.97.21.11466. PMC 17223. PMID 11027346.
“NMR structure of a biologically active peptide containing the RNA-binding domain of human immunodeficiency virus type 1 Tat”. Proc. Natl. Acad. Sci. U.S.A. 91 (17): 8248–52. (August 1994). Bibcode: 1994PNAS...91.8248M. doi:10.1073/pnas.91.17.8248. PMC 44583. PMID 8058789.
“Crystal structure of HIV-1 Tat complexed with human P-TEFb”. Nature 465 (7299): 747–51. (June 2010). Bibcode: 2010Natur.465..747T. doi:10.1038/nature09131. PMC 2885016. PMID 20535204.
“Direct interaction of human TFIID with the HIV-1 transactivator Tat”. Nature 367 (6460): 295–9. (January 1994). Bibcode: 1994Natur.367..295K. doi:10.1038/367295a0. PMID 8121496.

nih.gov

pubmed.ncbi.nlm.nih.gov

“The ins and outs of HIV-1 Tat.”. Traffic 13 (3): 355–63. (2012). doi:10.1111/j.1600-0854.2011.01286.x. PMID 21951552.
“Positive transcription elongation factor B phosphorylates hSPT5 and RNA polymerase II carboxyl-terminal domain independently of cyclin-dependent kinase-activating kinase”. J. Biol. Chem. 276 (15): 12317–23. (April 2001). doi:10.1074/jbc.M010908200. PMID 11145967.
“Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1”. Proc. Natl. Acad. Sci. U.S.A. 97 (21): 11466–71. (October 2000). Bibcode: 2000PNAS...9711466X. doi:10.1073/pnas.97.21.11466. PMC 17223. PMID 11027346.
“The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis”. J. Biol. Chem. 279 (46): 48197–204. (November 2004). doi:10.1074/jbc.M406195200. PMID 15331610.
“The biochemistry of AIDS”. Annu. Rev. Biochem. 60: 577–630. (1991). doi:10.1146/annurev.bi.60.070191.003045. PMID 1883204.
“NMR structure of a biologically active peptide containing the RNA-binding domain of human immunodeficiency virus type 1 Tat”. Proc. Natl. Acad. Sci. U.S.A. 91 (17): 8248–52. (August 1994). Bibcode: 1994PNAS...91.8248M. doi:10.1073/pnas.91.17.8248. PMC 44583. PMID 8058789.
“A bimolecular mechanism of HIV-1 Tat protein interaction with RNA polymerase II transcription elongation complexes”. J. Mol. Biol. 320 (5): 925–42. (July 2002). doi:10.1016/S0022-2836(02)00556-9. PMID 12126615.
“Trans-activation by HIV-1 Tat via a heterologous RNA binding protein”. Cell 62 (4): 769–76. (August 1990). doi:10.1016/0092-8674(90)90121-T. PMID 2117500.
“Crystal structure of HIV-1 Tat complexed with human P-TEFb”. Nature 465 (7299): 747–51. (June 2010). Bibcode: 2010Natur.465..747T. doi:10.1038/nature09131. PMC 2885016. PMID 20535204.
“Direct interaction of human TFIID with the HIV-1 transactivator Tat”. Nature 367 (6460): 295–9. (January 1994). Bibcode: 1994Natur.367..295K. doi:10.1038/367295a0. PMID 8121496.
“Protein transduction: unrestricted delivery into all cells?”. Trends Cell Biol. 10 (7): 290–5. (July 2000). doi:10.1016/S0962-8924(00)01771-2. PMID 10856932.
“Delivery of bioactive molecules into the cell: the Trojan horse approach”. Molecular and Cellular Neuroscience 27 (2): 85–131. (October 2004). doi:10.1016/j.mcn.2004.03.005. PMID 15485768. https://zenodo.org/record/890801.
“Cellular uptake of the tat protein from human immunodeficiency virus”. Cell 55 (6): 1189–93. (December 1988). doi:10.1016/0092-8674(88)90263-2. PMID 2849510.
“Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein”. Cell 55 (6): 1179–88. (December 1988). doi:10.1016/0092-8674(88)90262-0. PMID 2849509.
MacKay, J. Andrew; Szoka, Jr., Francis C. (2003). “HIV TAT Protein Transduction Domain Mediated Cell Binding and Intracellular Delivery of Nanoparticles”. Journal of Dispersion Science and Technology 24 (3): 465–473. doi:10.1081/dis-120021802. PMC 2929673. PMID 20808712.
Silhol, Michelle; Tyagi, Mudit; Giacca, Mauro; Lebleu, Bernard; Vivès, Eric (2002). “Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat”. European Journal of Biochemistry 269 (2): 494–501. doi:10.1046/j.0014-2956.2001.02671.x. PMID 11856307.
Eguchi, Akiko; Akuta, Teruo; Okuyama, Hajime et al. (2001). “Protein Transduction Domain of HIV-1 Tat Protein Promotes Efficient Delivery of DNA into Mammalian Cells”. Journal of Biological Chemistry 276 (28): 26204–26210. doi:10.1074/jbc.M010625200. PMID 11346640.
“Structural and functional characterization of human immunodeficiency virus Tat protein”. Journal of Virology 63 (1): 1–8. (January 1989). doi:10.1128/JVI.63.1.1-8.1989. PMC 247650. PMID 2535718.
“Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein”. Journal of Virology 63 (3): 1181–7. (March 1989). doi:10.1128/JVI.63.3.1181-1187.1989. PMC 247813. PMID 2536828.
“Recruitment of phosphatidylinositol 3-kinase to CD28 inhibits HIV transcription by a Tat-dependent mechanism”. J. Immunol. 169 (1): 254–60. (July 2002). doi:10.4049/jimmunol.169.1.254. PMID 12077252.
“4-Phenylcoumarins as HIV transcription inhibitors”. Bioorg. Med. Chem. Lett. 15 (20): 4447–50. (October 2005). doi:10.1016/j.bmcl.2005.07.041. PMID 16137881.
“Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial”. Retrovirology 13: 21. (April 2016). doi:10.1186/s12977-016-0251-3. PMC 4818470. PMID 27036656.

ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov

meshb.nlm.nih.gov

Genes, tat - MeSH・アメリカ国立医学図書館・生命科学用語シソーラス（英語）

zenodo.org

“Delivery of bioactive molecules into the cell: the Trojan horse approach”. Molecular and Cellular Neuroscience 27 (2): 85–131. (October 2004). doi:10.1016/j.mcn.2004.03.005. PMID 15485768. https://zenodo.org/record/890801.